The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TACH101, a first-in-class pan-inhibitor of KDM4 for treatment of gastrointestinal cancers.
 
Frank Perabo
Employment - ALMS Therapeutics; Barricade Therapeutics; Hinova Pharmaceuticals; InnovatHealth; MAIA Biotechnology; Pattern Pharma; Tachyon Therapeutics
Leadership - Barricade Therapeutics; MAIA Biotechnology; Tachyon Therapeutics
Stock and Other Ownership Interests - Assembly Biosciences; Aurinia Pharmaceuticals; Barricade Therapeutics; Black Diamond Therapeutics; ESSA; MAIA Biotechnology; Tachyon Therapeutics; Turning Point Therapeutics
Consulting or Advisory Role - ALMS Therapeutics; Hinova Pharmaceuticals; Pattern Pharma
 
Chandtip Chandhasin
Employment - Tachyon Therapeutics
Stock and Other Ownership Interests - Medicenna
 
Sanghee Yoo
Employment - ImmunoMET
Leadership - ImmunoMET
Stock and Other Ownership Interests - ImmunoMET
Consulting or Advisory Role - Tachyon Therapeutics
Patents, Royalties, Other Intellectual Property - ImmunoMET
 
Van Dang
Employment - Tachyon Therapeutics
 
Joselyn Del Rosario
Employment - Bristol-Myers Squibb
 
Young K Chen
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Quanticel Pharma
 
Jeffrey Stafford
Employment - 858 Therapeutics
Leadership - 858 Therapeutics
Stock and Other Ownership Interests - 858 Therapeutics
Consulting or Advisory Role - Tachyon Therapeutics
 
Stephen Quake
Leadership - Tachyon Therapeutics
Stock and Other Ownership Interests - Tachyon Therapeutics
Patents, Royalties, Other Intellectual Property - Tachyon Therapeutics
 
Michael F. Clarke
Leadership - Tachyon Therapeutics
Stock and Other Ownership Interests - Tachyon Therapeutics
Patents, Royalties, Other Intellectual Property - Tachyon Therapeutics